686 related articles for article (PubMed ID: 30119258)
1. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 signaling contributes to renal fibrosis following ischemia reperfusion.
Liang H; Xu F; Wen XJ; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Eur J Pharmacol; 2017 Oct; 812():18-27. PubMed ID: 28668506
[TBL] [Abstract][Full Text] [Related]
3. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.
Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H
Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644
[TBL] [Abstract][Full Text] [Related]
4. The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury.
Lux M; Blaut A; Eltrich N; Bideak A; Müller MB; Hoppe JM; Gröne HJ; Locati M; Vielhauer V
Am J Pathol; 2019 Feb; 189(2):231-247. PubMed ID: 30448408
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.
Yin J; Wang F; Kong Y; Wu R; Zhang G; Wang N; Wang L; Lu Z; Liang M
J Cell Mol Med; 2017 Dec; 21(12):3506-3514. PubMed ID: 28767184
[TBL] [Abstract][Full Text] [Related]
7. IL-17A blockade or deficiency does not affect progressive renal fibrosis following renal ischaemia reperfusion injury in mice.
Thorenz A; Völker N; Bräsen JH; Chen R; Jang MS; Rong S; Haller H; Kirsch T; Vieten G; Klemann C; Gueler F
J Pharm Pharmacol; 2017 Sep; 69(9):1125-1135. PubMed ID: 28573734
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of Rac1 exerts a protective role in ischemia/reperfusion-induced renal fibrosis.
Liang H; Huang J; Huang Q; Xie YC; Liu HZ; Wang HB
Biochem Biophys Res Commun; 2018 Sep; 503(4):2517-2523. PubMed ID: 30208520
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase γ deficiency attenuates kidney injury and fibrosis in angiotensin II-induced hypertension.
An C; Wen J; Hu Z; Mitch WE; Wang Y
Nephrol Dial Transplant; 2020 Sep; 35(9):1491-1500. PubMed ID: 32500132
[TBL] [Abstract][Full Text] [Related]
10. Recruitment and subsequent proliferation of bone marrow-derived cells in the postischemic kidney are important to the progression of fibrosis.
Jang HS; Kim JI; Han SJ; Park KM
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1451-61. PubMed ID: 24740786
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived Ly6C
Yang Q; Wang Y; Pei G; Deng X; Jiang H; Wu J; Zhou C; Guo Y; Yao Y; Zeng R; Xu G
Cell Death Dis; 2019 Mar; 10(4):291. PubMed ID: 30926787
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor 5 blockade modulates macrophage trafficking in renal ischaemic-reperfusion injury.
Yoo KD; Cha RH; Lee S; Kim JE; Kim KH; Lee JS; Kim DK; Kim YS; Yang SH
J Cell Mol Med; 2020 May; 24(10):5515-5527. PubMed ID: 32227583
[TBL] [Abstract][Full Text] [Related]
13. CXCL16/ROCK1 signaling pathway exacerbates acute kidney injury induced by ischemia-reperfusion.
Liang H; Liao M; Zhao W; Zheng X; Xu F; Wang H; Huang J
Biomed Pharmacother; 2018 Feb; 98():347-356. PubMed ID: 29275176
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase 1 activation links ischemic acute kidney injury to interstitial fibrosis.
Yoon SP; Kim J
J Physiol Sci; 2015 Jan; 65(1):105-11. PubMed ID: 25388944
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
16. The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling.
Barrera-Chimal J; Estrela GR; Lechner SM; Giraud S; El Moghrabi S; Kaaki S; Kolkhof P; Hauet T; Jaisser F
Kidney Int; 2018 Jun; 93(6):1344-1355. PubMed ID: 29548765
[TBL] [Abstract][Full Text] [Related]
17. Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL-33/ST2 to Alleviate Renal Ischemia-Reperfusion Injury.
Xu L; Xing Z; Yuan J; Han Y; Jiang Z; Han M; Hou X; Xing W; Li Z
Adv Healthc Mater; 2024 May; 13(13):e2303276. PubMed ID: 38335143
[TBL] [Abstract][Full Text] [Related]
18. IL-18 contributes to renal damage after ischemia-reperfusion.
Wu H; Craft ML; Wang P; Wyburn KR; Chen G; Ma J; Hambly B; Chadban SJ
J Am Soc Nephrol; 2008 Dec; 19(12):2331-41. PubMed ID: 18815244
[TBL] [Abstract][Full Text] [Related]
19. TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization.
Hu X; Xu Y; Zhang Z; Tang Z; Zhang J; Luo Y; Deng W; Dong Z; Zhao Y; Na N
Front Immunol; 2021; 12():637335. PubMed ID: 33767704
[TBL] [Abstract][Full Text] [Related]
20. IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury.
Zhang MZ; Wang X; Wang Y; Niu A; Wang S; Zou C; Harris RC
Kidney Int; 2017 Feb; 91(2):375-386. PubMed ID: 27745702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
